Aspen Pharmacare (LDZU) Income Statement

1 Followers

Aspen Pharmacare Income Statement

Last quarter (Q4 2026), Aspen Pharmacare's total revenue was Rs18.40B, a decrease of -21.93% from the same quarter last year. In Q4, Aspen Pharmacare's net income was Rs1.21B. See Aspen Pharmacare’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Jun 26	Jun 25	Jun 24	Jun 23	Jun 22
Total Revenue	Rs 34.14B	Rs 43.36B	Rs 44.71B	Rs 40.71B	Rs 38.61B
Gross Profit	Rs 13.76B	Rs 19.13B	Rs 19.42B	Rs 18.41B	Rs 18.31B
Operating Expenses	Rs 8.48B	Rs 17.69B	Rs 12.42B	Rs 11.05B	Rs 9.63B
Depreciation and Amortization	Rs 1.88B	Rs 635.00M	Rs 1.97B	Rs 1.26B	Rs 1.19B
EBITDA	Rs 7.16B	Rs 2.16B	Rs 9.90B	Rs 10.19B	Rs 9.93B
Operating Income	Rs 5.29B	Rs 1.44B	Rs 7.00B	Rs 7.82B	Rs 8.67B
Other Income/Expenses	Rs -5.70B	Rs -1.56B	Rs -1.28B	Rs -1.27B	Rs -537.00M
Pretax Income	Rs -409.30M	Rs -123.00M	Rs 5.71B	Rs 6.55B	Rs 8.13B
Net Income	Rs 2.59B	Rs -1.08B	Rs 4.40B	Rs 5.23B	Rs 6.49B
Per Share Metrics
Basic EPS	Rs 5.79	Rs -2.44	Rs 9.91	Rs 11.77	Rs 14.32
Diluted EPS	Rs 5.79	Rs -2.44	Rs 9.91	Rs 11.77	Rs 14.32
Weighted Average Shares Outstanding	444.10M	444.20M	444.20M	444.20M	453.00M
Weighted Average Shares Outstanding (Diluted)	444.10M	444.20M	444.20M	444.20M	453.00M

Currency in ZAR

Aspen Pharmacare (LDZU) Income Statement

Aspen Pharmacare Income Statement

Aspen Pharmacare Earnings and Revenue History